Sydney Head and Neck Cancer Institute, Sydney, Australia.
Cancer. 2011 Jul 1;117(13):2917-25. doi: 10.1002/cncr.25834. Epub 2011 Jan 18.
Elective neck dissection (END) is commonly used as a staging and therapeutic procedure for oral squamous cell carcinoma (SCC) at high risk of nodal metastases. The authors aimed to determine whether the extent of lymphadenectomy, as defined by nodal yield, is a prognostic factor in this setting.
A retrospective database review identified 225 patients undergoing END with curative intent for oral SCC between 1987 and 2009. Nodal yield was studied as a categorical variable for association with overall, disease-specific, and disease-free survival in univariate and multivariate analyses.
Nodal yield <18 was associated with 5-year overall survival of 51% compared with 74% in those with nodal yield ≥ 18 (P = .009). Five-year disease-specific survival rates were 69% in those with <18 nodes and 87% in patients with ≥ 18 nodes (P = .022). Similar results were obtained for disease-free survival, with 5-year rates of 44% with <18 nodes versus 71% with ≥ 18 nodes (P = .043). After adjusting for the effect of age, nodal status, T stage, and adjuvant radiotherapy on multivariate analysis, nodal yield <18 was associated with reduced overall (hazard ratio [HR], 2.0; 95% confidence interval [CI], 1.1-3.6; P = .020), disease-specific (HR, 2.2; 95% CI, 1.1-4.5; P = .043), and disease-free survival (HR, 1.7; 95% CI, 1.1-2.8; P = .040). In the pathologically lymph node-negative subgroup (n = 148), similar results were obtained.
Nodal yield is an independent prognostic factor in patients undergoing END for oral SCC. These results suggest that an adequate lymphadenectomy in this setting should include at least 18 nodes.
选择性颈清扫术(END)常用于治疗有淋巴结转移高风险的口腔鳞状细胞癌(SCC)的分期和治疗。作者旨在确定淋巴结切除术的范围(以淋巴结检出数定义)是否为该情况下的预后因素。
对 1987 年至 2009 年间 225 例因口腔 SCC 接受根治性 END 的患者进行回顾性数据库研究。将淋巴结检出数作为分类变量,用于单变量和多变量分析中与总生存率、疾病特异性生存率和无病生存率的相关性研究。
淋巴结检出数<18 与 5 年总生存率 51%相关,而检出数≥18 与 74%相关(P=.009)。检出数<18 的患者 5 年疾病特异性生存率为 69%,检出数≥18 的患者为 87%(P=.022)。无病生存率也得到相似结果,检出数<18 的患者 5 年无病生存率为 44%,检出数≥18 的患者为 71%(P=.043)。在校正年龄、淋巴结状态、T 分期和辅助放疗对多变量分析的影响后,淋巴结检出数<18 与总生存率降低相关(风险比[HR],2.0;95%置信区间[CI],1.1-3.6;P=.020)、疾病特异性生存率(HR,2.2;95% CI,1.1-4.5;P=.043)和无病生存率(HR,1.7;95% CI,1.1-2.8;P=.040)。在病理淋巴结阴性亚组(n=148)中也得到相似结果。
淋巴结检出数是接受 END 治疗的口腔 SCC 患者的独立预后因素。这些结果表明,在此情况下,充分的淋巴结切除术应至少包括 18 个淋巴结。